Dendrite International Signs Agreement With the Sanofi-Aventis Group

Dendrite International, a leading provider of sales, marketing and clinical solutions for the life science and pharmaceutical industries, announced that it signed a comprehensive, five-year software and services agreement with the sanofi-aventis Group in the U.S., the third largest pharmaceutical company in the world and the largest in Europe. Dendrite indicated that the total contract value was the second largest in the company's history, and would result in sanofi-aventis becoming the company's second largest customer.

BioSpace (http://www.biospace.com/news_story.cfm?StoryId=19638720)